questionsmedicales.fr
Enzymes et coenzymes
Enzymes
Oxidoreductases
Oxygénases
Mixed function oxygenases
Mixed function oxygenases : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Mixed function oxygenases : Questions médicales les plus fréquentes",
"headline": "Mixed function oxygenases : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Mixed function oxygenases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-08",
"dateModified": "2025-04-04",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Mixed function oxygenases"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Oxygénases",
"url": "https://questionsmedicales.fr/mesh/D010105",
"about": {
"@type": "MedicalCondition",
"name": "Oxygénases",
"code": {
"@type": "MedicalCode",
"code": "D010105",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Benzoate 4-monooxygenase",
"alternateName": "Benzoate 4-Monooxygenase",
"url": "https://questionsmedicales.fr/mesh/D050565",
"about": {
"@type": "MedicalCondition",
"name": "Benzoate 4-monooxygenase",
"code": {
"@type": "MedicalCode",
"code": "D050565",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.062"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Catechol oxidase",
"alternateName": "Catechol Oxidase",
"url": "https://questionsmedicales.fr/mesh/D004156",
"about": {
"@type": "MedicalCondition",
"name": "Catechol oxidase",
"code": {
"@type": "MedicalCode",
"code": "D004156",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.125"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Monophenol monooxygenase",
"alternateName": "Monophenol Monooxygenase",
"url": "https://questionsmedicales.fr/mesh/D014442",
"about": {
"@type": "MedicalCondition",
"name": "Monophenol monooxygenase",
"code": {
"@type": "MedicalCode",
"code": "D014442",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.125.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "7-Alkoxycoumarin O-dealkylase",
"alternateName": "7-Alkoxycoumarin O-Dealkylase",
"url": "https://questionsmedicales.fr/mesh/D015660",
"about": {
"@type": "MedicalCondition",
"name": "7-Alkoxycoumarin O-dealkylase",
"code": {
"@type": "MedicalCode",
"code": "D015660",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.170.010.024"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dopamine beta-monooxygenase",
"alternateName": "Dopamine beta-Hydroxylase",
"url": "https://questionsmedicales.fr/mesh/D004299",
"about": {
"@type": "MedicalCondition",
"name": "Dopamine beta-monooxygenase",
"code": {
"@type": "MedicalCode",
"code": "D004299",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.292"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Fatty acid desaturases",
"alternateName": "Fatty Acid Desaturases",
"url": "https://questionsmedicales.fr/mesh/D044943",
"about": {
"@type": "MedicalCondition",
"name": "Fatty acid desaturases",
"code": {
"@type": "MedicalCode",
"code": "D044943",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.392"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "beta-Carotene 15,15'-monooxygenase",
"alternateName": "beta-Carotene 15,15'-Monooxygenase",
"url": "https://questionsmedicales.fr/mesh/D050559",
"about": {
"@type": "MedicalCondition",
"name": "beta-Carotene 15,15'-monooxygenase",
"code": {
"@type": "MedicalCode",
"code": "D050559",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.392.312"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Delta-5 fatty acid desaturase",
"alternateName": "Delta-5 Fatty Acid Desaturase",
"url": "https://questionsmedicales.fr/mesh/D000090943",
"about": {
"@type": "MedicalCondition",
"name": "Delta-5 fatty acid desaturase",
"code": {
"@type": "MedicalCode",
"code": "D000090943",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.392.390"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Linoleoyl-CoA desaturase",
"alternateName": "Linoleoyl-CoA Desaturase",
"url": "https://questionsmedicales.fr/mesh/D050602",
"about": {
"@type": "MedicalCondition",
"name": "Linoleoyl-CoA desaturase",
"code": {
"@type": "MedicalCode",
"code": "D050602",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.392.468"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Acyl-(acyl-carrier-protein)desaturase",
"alternateName": "Stearoyl-CoA Desaturase",
"url": "https://questionsmedicales.fr/mesh/D013230",
"about": {
"@type": "MedicalCondition",
"name": "Acyl-(acyl-carrier-protein)desaturase",
"code": {
"@type": "MedicalCode",
"code": "D013230",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.392.625"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "gamma-butyrobetaine dioxygenase",
"alternateName": "gamma-Butyrobetaine Dioxygenase",
"url": "https://questionsmedicales.fr/mesh/D050563",
"about": {
"@type": "MedicalCondition",
"name": "gamma-butyrobetaine dioxygenase",
"code": {
"@type": "MedicalCode",
"code": "D050563",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.401"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Heme oxygenase (decyclizing)",
"alternateName": "Heme Oxygenase (Decyclizing)",
"url": "https://questionsmedicales.fr/mesh/D006419",
"about": {
"@type": "MedicalCondition",
"name": "Heme oxygenase (decyclizing)",
"code": {
"@type": "MedicalCode",
"code": "D006419",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.410"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Heme oxygenase-1",
"alternateName": "Heme Oxygenase-1",
"url": "https://questionsmedicales.fr/mesh/D051547",
"about": {
"@type": "MedicalCondition",
"name": "Heme oxygenase-1",
"code": {
"@type": "MedicalCode",
"code": "D051547",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.410.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "4-Hydroxybenzoate 3-monooxygenase",
"alternateName": "4-Hydroxybenzoate-3-Monooxygenase",
"url": "https://questionsmedicales.fr/mesh/D015109",
"about": {
"@type": "MedicalCondition",
"name": "4-Hydroxybenzoate 3-monooxygenase",
"code": {
"@type": "MedicalCode",
"code": "D015109",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.425"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Kynurenine 3-monooxygenase",
"alternateName": "Kynurenine 3-Monooxygenase",
"url": "https://questionsmedicales.fr/mesh/D050601",
"about": {
"@type": "MedicalCondition",
"name": "Kynurenine 3-monooxygenase",
"code": {
"@type": "MedicalCode",
"code": "D050601",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.557"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Phenylalanine 4-monooxygenase",
"alternateName": "Phenylalanine Hydroxylase",
"url": "https://questionsmedicales.fr/mesh/D010651",
"about": {
"@type": "MedicalCondition",
"name": "Phenylalanine 4-monooxygenase",
"code": {
"@type": "MedicalCode",
"code": "D010651",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.601"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Procollagen-lysine, 2-oxoglutarate 5-dioxygenase",
"alternateName": "Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase",
"url": "https://questionsmedicales.fr/mesh/D008240",
"about": {
"@type": "MedicalCondition",
"name": "Procollagen-lysine, 2-oxoglutarate 5-dioxygenase",
"code": {
"@type": "MedicalCode",
"code": "D008240",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.660"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Prolyl hydroxylases",
"alternateName": "Prolyl Hydroxylases",
"url": "https://questionsmedicales.fr/mesh/D064828",
"about": {
"@type": "MedicalCondition",
"name": "Prolyl hydroxylases",
"code": {
"@type": "MedicalCode",
"code": "D064828",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.694"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hypoxia-inducible factor-proline dioxygenases",
"alternateName": "Hypoxia-Inducible Factor-Proline Dioxygenases",
"url": "https://questionsmedicales.fr/mesh/D064799",
"about": {
"@type": "MedicalCondition",
"name": "Hypoxia-inducible factor-proline dioxygenases",
"code": {
"@type": "MedicalCode",
"code": "D064799",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.694.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Procollagen-Proline Dioxygenase",
"alternateName": "Procollagen-Proline Dioxygenase",
"url": "https://questionsmedicales.fr/mesh/D011393",
"about": {
"@type": "MedicalCondition",
"name": "Procollagen-Proline Dioxygenase",
"code": {
"@type": "MedicalCode",
"code": "D011393",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.694.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Prostaglandin-endoperoxide synthases",
"alternateName": "Prostaglandin-Endoperoxide Synthases",
"url": "https://questionsmedicales.fr/mesh/D011451",
"about": {
"@type": "MedicalCondition",
"name": "Prostaglandin-endoperoxide synthases",
"code": {
"@type": "MedicalCode",
"code": "D011451",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.715"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Squalene monooxygenase",
"alternateName": "Squalene Monooxygenase",
"url": "https://questionsmedicales.fr/mesh/D050603",
"about": {
"@type": "MedicalCondition",
"name": "Squalene monooxygenase",
"code": {
"@type": "MedicalCode",
"code": "D050603",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.749"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Trans-cinnamate 4-monooxygenase",
"alternateName": "Trans-Cinnamate 4-Monooxygenase",
"url": "https://questionsmedicales.fr/mesh/D050564",
"about": {
"@type": "MedicalCondition",
"name": "Trans-cinnamate 4-monooxygenase",
"code": {
"@type": "MedicalCode",
"code": "D050564",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.826"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Tryptophane 5-monooxygenase",
"alternateName": "Tryptophan Hydroxylase",
"url": "https://questionsmedicales.fr/mesh/D014365",
"about": {
"@type": "MedicalCondition",
"name": "Tryptophane 5-monooxygenase",
"code": {
"@type": "MedicalCode",
"code": "D014365",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.870"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vitamin K epoxide reductases",
"alternateName": "Vitamin K Epoxide Reductases",
"url": "https://questionsmedicales.fr/mesh/D064417",
"about": {
"@type": "MedicalCondition",
"name": "Vitamin K epoxide reductases",
"code": {
"@type": "MedicalCode",
"code": "D064417",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.961"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Mixed function oxygenases",
"alternateName": "Mixed Function Oxygenases",
"code": {
"@type": "MedicalCode",
"code": "D006899",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Shuyue Wang",
"url": "https://questionsmedicales.fr/author/Shuyue%20Wang",
"affiliation": {
"@type": "Organization",
"name": "MOE Key Laboratory of Molecular Genetics and Breeding, College of Marine Life Sciences, Ocean University of China, Qingdao 266003, China."
}
},
{
"@type": "Person",
"name": "Liang Zhao",
"url": "https://questionsmedicales.fr/author/Liang%20Zhao",
"affiliation": {
"@type": "Organization",
"name": "MOE Key Laboratory of Molecular Genetics and Breeding, College of Marine Life Sciences, Ocean University of China, Qingdao 266003, China."
}
},
{
"@type": "Person",
"name": "Tingting Li",
"url": "https://questionsmedicales.fr/author/Tingting%20Li",
"affiliation": {
"@type": "Organization",
"name": "MOE Key Laboratory of Molecular Genetics and Breeding, College of Marine Life Sciences, Ocean University of China, Qingdao 266003, China."
}
},
{
"@type": "Person",
"name": "Huizhen Wang",
"url": "https://questionsmedicales.fr/author/Huizhen%20Wang",
"affiliation": {
"@type": "Organization",
"name": "MOE Key Laboratory of Molecular Genetics and Breeding, College of Marine Life Sciences, Ocean University of China, Qingdao 266003, China."
}
},
{
"@type": "Person",
"name": "Zhenmin Bao",
"url": "https://questionsmedicales.fr/author/Zhenmin%20Bao",
"affiliation": {
"@type": "Organization",
"name": "MOE Key Laboratory of Molecular Genetics and Breeding, College of Marine Life Sciences, Ocean University of China, Qingdao 266003, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Strengthening systems of care for people with or at risk for HIV, HCV and opioid use disorder: a call for enhanced data collection.",
"datePublished": "2022-07-01",
"url": "https://questionsmedicales.fr/article/35775786",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/07853890.2022.2084154"
}
},
{
"@type": "ScholarlyArticle",
"name": "Head and Neck Paraganglioma (HNPGL) Registry: A study protocol for prospective data collection in patients with Head and Neck Paragangliomas.",
"datePublished": "2024-07-25",
"url": "https://questionsmedicales.fr/article/39052568",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0307311"
}
},
{
"@type": "ScholarlyArticle",
"name": "Streamlining electronic reporting of serious adverse events (SAEs) using the REDCap data collection system: the eSAE Project.",
"datePublished": "2024-07-24",
"url": "https://questionsmedicales.fr/article/39044237",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13063-024-08317-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Data collection within patient support programs in Canada and implications for real-world evidence generation: the authors' perspective.",
"datePublished": "2023-10-13",
"url": "https://questionsmedicales.fr/article/37901362",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/jpps.2023.11877"
}
},
{
"@type": "ScholarlyArticle",
"name": "Bringing the Clinic Home: An At-Home Multi-Modal Data Collection Ecosystem to Support Adaptive Deep Brain Stimulation.",
"datePublished": "2023-07-14",
"url": "https://questionsmedicales.fr/article/37522736",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3791/65305"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Enzymes et coenzymes",
"item": "https://questionsmedicales.fr/mesh/D045762"
},
{
"@type": "ListItem",
"position": 3,
"name": "Enzymes",
"item": "https://questionsmedicales.fr/mesh/D004798"
},
{
"@type": "ListItem",
"position": 4,
"name": "Oxidoreductases",
"item": "https://questionsmedicales.fr/mesh/D010088"
},
{
"@type": "ListItem",
"position": 5,
"name": "Oxygénases",
"item": "https://questionsmedicales.fr/mesh/D010105"
},
{
"@type": "ListItem",
"position": 6,
"name": "Mixed function oxygenases",
"item": "https://questionsmedicales.fr/mesh/D006899"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Mixed function oxygenases - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Mixed function oxygenases",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Mixed function oxygenases",
"description": "Comment diagnostiquer une dysfonction des oxydases à fonction mixte ?\nQuels tests sont utilisés pour évaluer l'activité des oxydases ?\nLes tests génétiques sont-ils utiles pour ces enzymes ?\nQuels symptômes peuvent indiquer une anomalie enzymatique ?\nComment les antécédents médicaux aident-ils au diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D006899?mesh_terms=Data+Collection&page=9#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Mixed function oxygenases",
"description": "Quels sont les symptômes d'une déficience en oxydases ?\nPeut-on observer des symptômes neurologiques ?\nLes symptômes varient-ils selon les individus ?\nQuels signes cliniques sont associés à une suractivité enzymatique ?\nLes symptômes peuvent-ils être confondus avec d'autres maladies ?",
"url": "https://questionsmedicales.fr/mesh/D006899?mesh_terms=Data+Collection&page=9#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Mixed function oxygenases",
"description": "Comment prévenir les dysfonctionnements des oxydases ?\nL'éducation des patients est-elle importante ?\nLes bilans de santé réguliers aident-ils ?\nLes habitudes alimentaires influencent-elles la fonction enzymatique ?\nLes vaccinations ont-elles un impact sur la fonction enzymatique ?",
"url": "https://questionsmedicales.fr/mesh/D006899?mesh_terms=Data+Collection&page=9#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Mixed function oxygenases",
"description": "Quels traitements sont disponibles pour les dysfonctionnements enzymatiques ?\nLes suppléments peuvent-ils aider à la fonction enzymatique ?\nComment la pharmacogénétique influence-t-elle le traitement ?\nLes traitements sont-ils différents pour les enfants et les adultes ?\nDes thérapies géniques sont-elles envisagées ?",
"url": "https://questionsmedicales.fr/mesh/D006899?mesh_terms=Data+Collection&page=9#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Mixed function oxygenases",
"description": "Quelles complications peuvent survenir avec une dysfonction enzymatique ?\nLes complications sont-elles réversibles ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications sont-elles plus fréquentes chez certains groupes ?\nLes complications peuvent-elles être prévenues ?",
"url": "https://questionsmedicales.fr/mesh/D006899?mesh_terms=Data+Collection&page=9#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Mixed function oxygenases",
"description": "Quels sont les principaux facteurs de risque pour les dysfonctionnements enzymatiques ?\nL'âge influence-t-il le risque de dysfonctionnement ?\nLes maladies chroniques augmentent-elles le risque ?\nLe mode de vie joue-t-il un rôle dans le risque ?\nLes interactions médicamenteuses sont-elles un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D006899?mesh_terms=Data+Collection&page=9#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysfonction des oxydases à fonction mixte ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests enzymatiques et l'analyse des métabolites dans le sang."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'activité des oxydases ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de métabolisme des médicaments et des analyses biochimiques sont utilisés."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils utiles pour ces enzymes ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests génétiques peuvent identifier des mutations affectant l'activité enzymatique."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer une anomalie enzymatique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la toxicité médicamenteuse ou des réactions indésirables peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment les antécédents médicaux aident-ils au diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents d'exposition à des médicaments ou toxines peuvent orienter le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une déficience en oxydases ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des réactions médicamenteuses imprévues et une toxicité accrue."
}
},
{
"@type": "Question",
"name": "Peut-on observer des symptômes neurologiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes neurologiques peuvent survenir en raison d'une accumulation de toxines."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon les individus ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la gravité et le type de symptômes peuvent varier selon la génétique et l'environnement."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont associés à une suractivité enzymatique ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une suractivité peut entraîner une dégradation rapide des médicaments et des effets secondaires."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils être confondus avec d'autres maladies ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent ressembler à ceux d'autres maladies métaboliques ou hépatiques."
}
},
{
"@type": "Question",
"name": "Comment prévenir les dysfonctionnements des oxydases ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter l'exposition à des médicaments et toxines connus pour affecter ces enzymes."
}
},
{
"@type": "Question",
"name": "L'éducation des patients est-elle importante ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, informer les patients sur les risques liés aux médicaments est essentiel pour la prévention."
}
},
{
"@type": "Question",
"name": "Les bilans de santé réguliers aident-ils ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des bilans réguliers peuvent détecter précocement des anomalies enzymatiques."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires influencent-elles la fonction enzymatique ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée peut soutenir la santé enzymatique et métabolique."
}
},
{
"@type": "Question",
"name": "Les vaccinations ont-elles un impact sur la fonction enzymatique ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations peuvent influencer le métabolisme, mais les effets varient."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les dysfonctionnements enzymatiques ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des ajustements médicamenteux et des thérapies de soutien."
}
},
{
"@type": "Question",
"name": "Les suppléments peuvent-ils aider à la fonction enzymatique ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains suppléments peuvent améliorer la fonction enzymatique, selon le cas."
}
},
{
"@type": "Question",
"name": "Comment la pharmacogénétique influence-t-elle le traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La pharmacogénétique permet de personnaliser les traitements en fonction du profil enzymatique."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils différents pour les enfants et les adultes ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les dosages et les choix de médicaments peuvent varier entre enfants et adultes."
}
},
{
"@type": "Question",
"name": "Des thérapies géniques sont-elles envisagées ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des recherches sont en cours sur les thérapies géniques pour corriger les déficiences enzymatiques."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une dysfonction enzymatique ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des réactions médicamenteuses graves et des maladies hépatiques."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié, d'autres non."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent réduire la qualité de vie en limitant les options de traitement."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles plus fréquentes chez certains groupes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines populations peuvent être plus à risque en raison de facteurs génétiques."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être prévenues ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être évitées par une surveillance et un traitement précoce."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque pour les dysfonctionnements enzymatiques ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, l'exposition à des toxines et certains médicaments."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de dysfonctionnement ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque peut augmenter avec l'âge en raison de changements métaboliques."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies chroniques peuvent affecter la fonction enzymatique et augmenter le risque."
}
},
{
"@type": "Question",
"name": "Le mode de vie joue-t-il un rôle dans le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie malsain, comme une mauvaise alimentation, peut augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les interactions médicamenteuses sont-elles un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines interactions médicamenteuses peuvent altérer l'activité des oxydases à fonction mixte."
}
}
]
}
]
}
The syndemic between opioid use disorder (OUD), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) results in excessive burdens on the healthcare system. Integrating these siloed systems ...
Data for this study were gathered from publicly available datasets and reports from government (SAMSHA, CMS, HRSA and CDC) sites. We created, where possible, COCs for HIV, HCV, and OUD spanning popula...
The process of data collection showed that baseline COCs examining the intersections of OUD, HIV, and HCV cannot be produced and that there are missing data in all states examined. Collection of speci...
It is difficult to assess the strategies needed or the progress made towards increasing treatment access and decreasing the burden of disease without the ability to construct an accurate baseline. Usi...
There is a lack of comprehensive and uniform data on head and neck paragangliomas (HNPGLs), and research is challenging due to its rarity and the involvement of multiple medical specialties. To improv...
The HNPGL Registry is designed as a prospective longitudinal observational registry for data collection on HNPGL patients and carriers of (likely) pathogenic variants causative of HNPGLs. All patients...
The HNPGL Registry data will be used to further establish the optimal management for HNPGL patients and lay the foundation for guideline recommendations and the outline of future research....
It is essential that electronic data collection (EDC) systems are both compliant with regulations and the principles of Good Clinical Practice (GCP) to allow for the timely and accurate reporting of d...
A multi-disciplinary working group came together from a UK academic clinical trials unit (CTU) to establish if an electronic system could be created in the unit's open-source EDC system-REDCap, to man...
A module has been created in REDCap to facilitate electronic SAE reporting: enabling an AE form to automatically trigger an SAE form for any AE which is also a SAE, prepopulating relevant fields of th...
The eSAE Project coded into REDCap offers a unique way of populating SAE forms with information already entered in the initial AE forms as applicable, coupled with highlighting any updates during the ...
Patient support programs (PSPs) offer a unique opportunity to collect real-world data that can contribute to improving patient care and informing healthcare decision making. In this perspective articl...
Adaptive deep brain stimulation (aDBS) shows promise for improving treatment for neurological disorders such as Parkinson's disease (PD). aDBS uses symptom-related biomarkers to adjust stimulation par...
There is increasing interest in collecting sociodemographic and social needs data in hospital settings to inform patient care and health equity. However, few studies have examined inpatients' views on...
A qualitative interpretive description methodology was used. Semi-structured interviews were conducted with 18 patients admitted to a large academic hospital in Toronto, Canada. Participants were recr...
Patients expressed that sociodemographic and social needs data collection is important to offer actionable solutions to address their needs. Patients described a gap between their ideal care which wou...
While the collection of sociodemographic and social needs information in hospital settings is generally acceptable, there were varied views on whether hospital staff should intervene, as their priorit...
The integration of health and activity data from various wearable devices into research studies presents technical and operational challenges. The Awesome Data Acquisition Method (ADAM) is a versatile...
Recently, unmanned aerial vehicles (UAVs) have emerged as a viable solution for data collection from remote Internet of Things (IoT) applications. However, the successful implementation in this regard...
The Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) seeks to provide comprehensive understanding of early-onset Alzheimer's disease (EOAD; onset <65 years), with the current study profiling...
Data from 371 LEADS participants were compared based on diagnostic group classification (cognitively normal [n = 89], amyloid-positive EOAD [n = 212], and amyloid-negative early-onset non-Alzheimer's ...
Cognitive performance was worse for EOAD than other groups, and EOAD participants were apolipoprotein E (APOE) ε4 homozygotes at higher rates. An amnestic presentation was common among impaired partic...
We present the most comprehensive baseline characterization of sporadic EOAD in the United States to date. EOAD presents with widespread cognitive impairment within and across clinical phenotypes, wit...
Findings represent the most comprehensive baseline characterization of sporadic early-onset Alzheimer's disease (EOAD) to date. Cognitive impairment was widespread for EOAD participants and more sever...
Recruitment for surveys has been a great challenge, especially in general practice....
Here, we reported recruitment strategies, data collection, participation rates (PR) and representativeness of the PRICOV-19 study, an international comparative, cross-sectional, online survey among ge...
Nine (24%) countries reported a published invitation; 19 (50%) had direct contact with all GPs/GP practices; 19 (50%) contacted a sample of GPs /GP practices; and 7 (18%) used another invitation strat...
Our main contribution here was to describe the survey recruitment and representativeness of PRICOV-19, an important and novel study....